Love how this company offers diagnostic products and veterinarian management systems, and is integrating these into a single service. People love their pets and this company is on top of a very niche area. This stock should continue to outperform over the next few years.

Idexx fell for a while after the split in november, but has leveled off and is starting back up again. i dont think it will go down again based on the fact that it is the largest vet supply company with the best equipment. it uses animal blood for equipment testing rather than human blood, which doctors like because it is a lot safer against disease. They have new equipment out that is starting to be sold on a larger scale. this company is not going anywhere (but up).

Idexx is the dominate player in the veterinary diagnostic business. Six or seven years ago they launched lazorcyte, a hematology machine that, althought expensive, they have been able to place into a ever growing impressive list of progressive veterinary practices. Now they have launched Catalist, a new revolutionary new blood chemistry devise, that I believe will show the sam type of growth. the great thing about Idexx is not only do they do well with the machines, each machine requires high profit consumables. One look at Idexx history since the launch of Lazorcyte, give me reason to believe catalyst will do the same for their stock for the forseeable future.